<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.SourceSummaryOutput xmlns:ns2="local"><SourceId>1108041</SourceId><Description>Press Release</Description><Title>vasopharm's trauma compound VAS203 successfully completes first-in-man study</Title><Authors><Author>vasopharm GmbH</Author></Authors><PublicationDetails><Date>2007-07-19T00:00:00Z</Date></PublicationDetails></ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.SourceSummaryOutput>